The stock price of Outset Medical Inc (NASDAQ: OM) has jumped by 4.17 compared to previous close of 2.16. Despite this, the company has seen a fall of -1.10% in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-18 that Outset Medical’s (OM) latest agreement is likely to provide patients and caregivers access to innovative home dialysis with the Tablo Hemodialysis System.
Is It Worth Investing in Outset Medical Inc (NASDAQ: OM) Right Now?
Additionally, the 36-month beta value for OM is 1.92. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for OM is 46.36M and currently, short sellers hold a 18.03% ratio of that float. The average trading volume of OM on April 19, 2024 was 1.01M shares.
OM’s Market Performance
OM’s stock has seen a -1.10% decrease for the week, with a 0.00% drop in the past month and a -35.53% fall in the past quarter. The volatility ratio for the week is 9.72%, and the volatility levels for the past 30 days are at 9.89% for Outset Medical Inc. The simple moving average for the past 20 days is 4.54% for OM’s stock, with a -71.28% simple moving average for the past 200 days.
Analysts’ Opinion of OM
Many brokerage firms have already submitted their reports for OM stocks, with BTIG Research repeating the rating for OM by listing it as a “Buy.” The predicted price for OM in the upcoming period, according to BTIG Research is $6 based on the research report published on April 08, 2024 of the current year 2024.
CL King, on the other hand, stated in their research note that they expect to see OM reach a price target of $6. The rating they have provided for OM stocks is “Buy” according to the report published on April 05th, 2024.
RBC Capital Mkts gave a rating of “Sector Perform” to OM, setting the target price at $6 in the report published on January 12th of the current year.
OM Trading at -16.54% from the 50-Day Moving Average
After a stumble in the market that brought OM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.68% of loss for the given period.
Volatility was left at 9.89%, however, over the last 30 days, the volatility rate increased by 9.72%, as shares surge +1.35% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -30.34% lower at present.
During the last 5 trading sessions, OM fell by -1.10%, which changed the moving average for the period of 200-days by -89.12% in comparison to the 20-day moving average, which settled at $2.15. In addition, Outset Medical Inc saw -58.41% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OM starting from Nash Marc, who sale 2,391 shares at the price of $2.13 back on Mar 15 ’24. After this action, Nash Marc now owns 242,510 shares of Outset Medical Inc, valued at $5,093 using the latest closing price.
Ahmed Nabeel, the Chief Financial Officer of Outset Medical Inc, sale 1,584 shares at $3.15 during a trade that took place back on Mar 01 ’24, which means that Ahmed Nabeel is holding 322,877 shares at $4,990 based on the most recent closing price.
Stock Fundamentals for OM
Current profitability levels for the company are sitting at:
- -1.3 for the present operating margin
- 0.22 for the gross margin
The net margin for Outset Medical Inc stands at -1.33. The total capital return value is set at -0.66. Equity return is now at value -93.69, with -48.41 for asset returns.
Based on Outset Medical Inc (OM), the company’s capital structure generated 0.53 points at debt to capital in total, while cash flow to debt ratio is standing at -0.96. The debt to equity ratio resting at 1.11. The interest coverage ratio of the stock is -13.39.
Currently, EBITDA for the company is -153.79 million with net debt to EBITDA at -0.43. When we switch over and look at the enterprise to sales, we see a ratio of 1.39. The receivables turnover for the company is 3.95for trailing twelve months and the total asset turnover is 0.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.26.
Conclusion
In conclusion, Outset Medical Inc (OM) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
